Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Laryngeal Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1 Advanced Intestinal Cancer 1

Interventions

Cetuximab 9 Cisplatin 8 Radiotherapy 7 Fluorouracil 5 pembrolizumab 3 Laser Therapy 3 Drug Therapy 3 Docetaxel 3 Resistance Training 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Psychiatric Rehabilitation 2 Nutritional Status 2 Hydroxyurea 2 Counseling 2 Celecoxib 2 Bupropion 2 Bronchoscopy 2 sargramostim 1 motexafin gadolinium 1 durvalumab 1 adavosertib 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sucralfate 1 Salts 1 Referral and Consultation 1 Polymerase Chain Reaction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430675 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡